TScan Therapeutics Inc. (TCRX)
Market Open
12 Jun, 13:53
NASDAQ (NMS) NASDAQ (NMS) Primary $
0. 93
+0.01
+0.7901%
$
62.3M Market Cap
- P/E Ratio
- Div Yield
23,580 Volume
-1.04 Eps
$ 0.92
Previous Close Investors:
Want to track TCRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
TScan Therapeutics Inc. (TCRX) Statistics
Valuation metrics
Market Cap 62.3M
Enterprise value -8.21M
Trailing P/E (ttm) -1.03
Forward P/E -
PEG ratio -0.09
Price/Sales (ttm) 6.56
Price/Book (mrq) 1.32
Enterprise Value/Revenue -0.9
Enterprise Value/EBITDA 0.07
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 313.02K
Average volume (90 days) 903.64K
Price summary
52-Week low 0.88
52-Week high 2.57
Beta -
50-Day moving average 1.16
200-Day moving average 1.07
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -13.61%
Operating margin -14.09%
Operational effectiveness
Return on assets -0.62%
Return on equity -0.92%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.07
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.96
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.99
Total debt (mrq) -
Total Debt/Equity (mrq) 0.62
Current ratio (mrq) 6.65%
Book value per share (mrq) 0.75
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
